Skip to main content
. 2015 Jun;35(4):63–72. doi: 10.24095/hpcdp.35.4.01

TABLE 4. Binomial logistic regression analysis of participants with prediabetesa and type 2 diabetesb with controls based on urinary arsenic concentration quartiles, CHMS, Cycle 1, 2007–2009.

Urinary arsenic (µg/L)c Number of participantsd Crude OR (95% CI) Adjusted OR (Model 1)e (95% CI) Adjusted OR (Model 2)f (95% CI)
Controls
(n=2054)
With prediabetesa
(n = 831)
With diabetesb
(n = 225)
Prediabetesa Diabetesb Prediabetesa Diabetesb Prediabetesa Diabetesb
< 5.71 554 171 46 1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 1.00 (Referent)
5.71–11.20 520 197 54 1.14 (0.86–1.52) 1.44 (1.08–1.92) 1.38 (0.87–2.21) 1.06 (0.60–1.87) 1.37 (0.88–2.17) 1.20 (0.70–2.05)
11.21–22.98 530 192 64 1.28 (0.92–1.62) 1.65 (1.07–2.54) 1.46 (0.92–2.32) 1.31 (0.63–2.74) 1.46 (0.92–2.35) 1.55 (0.83–2.90)
≥ 22.99 450 271 61 1.48 (1.18– 2.50) 1.92 (1.11–3.33) 2.04 (1.03–4.05) 1.54 (0.74–3.18) 2.14 (1.02–4.07) 1.81 (1.12–2.95)
p for trend .015 .019 .042 .246 .043 .017

Abbreviations: BMI, body mass index; CHMS, Canadian Health Measures Survey; CI, confidence interval; HbA1c, glycated hemoglobin; OR, odds ratio.

a

Fasting serum glucose 100–125 mg/dl (5.6–6.9 mmol/L) or HbA1c 5.7%–6.4%.

b

Fasting serum glucose ≥ 126 mg/dL or HbA1c ≥ 6.5% or self-reported medication use or self-reported health care professional diagnosis.

c

Urinary arsenic not corrected for urinary creatinine.

d

Data missing for n = 41 participants.

e

Model 1 adjusted for urinary creatinine, age, sex, alcohol status, smoking status, educational status, BMI and hypertension.

f

Model 2 adjusted as for Model 1 plus seafood consumption.